10 mg/ml
Trade Name
Sildenafil Amarox
Powder for oral suspension
Request Type
Registration
Drug Type
Generic Drug
Approval Date
SFDA Approved Use
Adults Treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. Paediatric population Treatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary
haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease
haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease